Tuesday, October 3, 2023
SUBSCRIBE
Tuesday, October 3, 2023

Contact: 561.316.3330

SUBSCRIBE
Search
HomeUltrasound

Esaote North America Announces a Multi-Year Contract with Vizient

Esaote North America announces a multi-year contract with Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, serving more than 50% of the nation’s acute care providers.

Esaote North America said the new agreement provides Vizient members access to contracts that offer increased savings on Esaote North America’s comprehensive Ultrasound product line and services, including the widely popular MyLabTM family portfolio.

“Our unique ultrasound portfolio is optimized for high performance in the most demanding clinical settings, covering a broad spectrum of clinical applications without compromising image quality or workflow efficiency,” said Robert Lewis, President and General Manager at Esaote North America.

Esaote North America is an internationally recognized leader that provides superior Ultrasound point-of-care solutions, Dedicated MRI systems, and Healthcare IT workflow solutions. Esaote’s founding philosophies continue to push the technological boundaries of the medical device industry, delivering cost-effective and eco-friendly diagnostic imaging solutions that meet customers’ needs worldwide.

SourceEsaote North America
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.
Read more

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 
Read more

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.
Read more

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 
Read more

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.
Read more

Medical Device News Magazine

Editorial Contact: mdnewsmagazine@infomeddnews.com

Medical Device News Magazine can help promote your medical devices, technologies, products or services. Advertising Contact: advmdn@infomeddnews.com

Telephone

© Copyright 2022 Medical Device News Magazine, is a division of PTM Healthcare Marketing, Inc

By using this website you agree to accept Medical Device News Magazine Privacy Policy